Associate ProfessorDino Premilovac

Associate Professor in Physiology

Medicine

  • Associate Professor in Physiology
    Medicine
  • +61 3 6226 2701 (Work)
  • Tasmanian School of Medicine, Medicine, 436 Medical Sciences 2, Hobart CBD Campuses, TAS

RESEARCH SUMMARy

Research Themes
Dino’s research aligns with Better Health theme of the University of Tasmania. His research aims to understand how the smallest blood vessels in the body, the capillaries, contribute to development and progression of disorders such as obesity-associated insulin resistance and type 2 diabetes. The first arm of his research focusses on understanding the contribution of blood flow dysregulation of development of insulin resistance and type 2 diabetes in tissues such as skeletal muscle and adipose tissue. These tissues are important regulators of metabolism and loss of normal blood flow response appear to manifest very early in disease progression. For this reason, Dino is also investigating whether exercise or pharmacological interventions can be protective or reverse progression of insulin resistance by restoring normal blood flow control in muscle and adipose tissue.

The second arm of his research focusses on investigating how insulin resistance and type 2 diabetes alter blood flow in the brain to promote disorders such as stroke and Alzheimer’s disease. He has pioneered a novel ultrasound based imaging technique to measure blood flow non-invasively and in real time in the intact brain and is using this technique to understand whether drugs can be used to improve brain blood flow in conditions such as diabetic stroke to reduce the severity of the brain damage and improve outcomes.

 

Areas of Expertise
Obesity

Insulin resistance 

Type 2 diabetes
Skeletal muscle physiology
Vascular imaging techniques
Cardiovascular physiology
Renin Angiotensin Aldosterone System
Stroke

Modelling human disease in rodents
Ultrasound imaging 



Collaboration
Selected past and present collaborations:
Professor Etto Eringa, VU University, Amsterdam: Deciphering the role of pericytes in skeletal muscle blood flow control
Professor Michelle Keske, IPAN, Deakin University: Consequences of microvascular dysfunction on metabolic disorders
Professor Kylie Kavanagh, Wake Forest School of Medicine: Capillary pericytes in non-human primate muscle

Awards
Dr Premilovac's 2013 manuscript published in the journal Cardiovascular Research was recognised as one of the 'Ten of the Best' scientific papers of the year by the Menzies Institute for Medical Research. The leading journal for diabetes research in Europe, Diabetologia, featured on the front cover of the 2014 December issue Dr Premilovac's work where he showed the negative impact of increased dietary salt on microvascular insulin sensitivity. Dino has also receieved the Michael Perry award from the Australian and New Zealand Microcircualtion Society for his excellence in vascular research.

Current projects
See lab website: https://www.utas.edu.au/health/research/groups/tasmanian-school-of-medicine/metabolism-and-vascular-research-group

FUNDED PROJECTS

  • GRANT
    Acquisition of a high-frequency ultrasound platform to supercharge discovery research in Tasmania
    1 Jan 2027 - 31 Dec 2029
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Young K,
    • Flies A,
    • Guven N
    Project Total: $141,000; This equipment grant application to the Ian Potter Foundation will lead to acquisition of a new, purpose built and state of the art ultrasound machine for preclinical work. Currently available machines at UTAS are clinical machines and are not able to adequately support preclinical imaging due to temporal and spatial resolution limits. This new machine will enable live in vivo imaging of any organ in the rat/mouse/zebra fish, measurement of cardiovascular function, targeted drug delivery using microbubbles (contrast agents) and an ultrasound guided micro-injection platform for delivery of compounds or genetic material without off target effects. Funded by: Ian Potter Foundation - Grant - Medical Research ($141,000); University of Tasmania ($141,000).
  • GRANT
    A Collaborative Multivariable Approach to Prevent the Spread of Corticomotor Dysfunction in ALS
    1 Jan 2023 - 31 Mar 2026
    People funded by this grant:
    • Blizzard C,
    • Walker A,
    • Balbi M,
    • Woodhouse A,
    • Premilovac D
    Project Total: $500,000; The most frequent presentation of a patient with ALS is increased motor cortex hyperexcitability and cytoplasmic build-up of TDP-43. It remains unclear how these pathophysiology lead to the widespread destruction of the corticomotor system. Our preliminary data indicates that TDP-43 in the cytoplasm may be causing neuronal hyperexcitability. We propose to discover (1) the cell signalling pathways that TDP-43 triggers hyperexcitability, (2) how upper motor neuron hyperexcitability spreads through the network (3) if different regions require altered excitability to be selectively and differentially modulated. This project may establish a novel and targeted drug delivery approach for patients with ALS. Funded by: Motor Neurone Disease Research Australia - Grant-Daniel McLoone MND Research Prize ($500,000); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Analysis of vascular integrity in acute stoke recovery
    1 Jan 2023 - 31 Dec 2023
    People funded by this grant:
    • Premilovac D
    Project Total: $38,615; This contract research will investigate the potential therapeutic effects of drugs designed by PAM-T in limiting brain damage after stroke. The work will be performed in preclinical models of stroke (rats) and the primary outcomes will be changes in brain damage and vascular integrity 24hrs after stroke with and without drug treatment. Funded by: PAM- Theragnostics GmbH ($38,615); University of Tasmania.
  • GRANT
    Understanding how breathing in air pollution leads to metabolic disease
    1 Jan 2023 - 30 Sep 2024
    People funded by this grant:
    • Premilovac D,
    • Richards S,
    • Zosky G,
    • Burgess J
    Project Total: $24,958; Exposure to air pollution is becoming recognised as a major risk factor for development of type 2 diabetes, particularly in people that are overweight or obese. Our study aims to understand if exposure to traffic pollution or wood fire smoke triggers development of insulin resistance, commonly known as pre-diabetes. Original title: Could particulate air pollution be contributing to the rise in development of Type 2 Diabetes? Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($24,958); University of Tasmania.
  • GRANT
    Understanding the role of insulin in the healthy and type 2 diabetic brain
    1 Jan 2023 - 30 Sep 2024
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Cullen C,
    • Foster C
    Project Total: $69,955; The aim of this project is to determine whether insulin has vascular and metabolic effects in specific regions of the brain and whether these effects are lost with insulin resistance and type 2 diabetes. This is pre-clinical work that will be performed in experimental rodents but the outcomes of the work will have wide relevance. Funded by: Diabetes Australia Research Program - Grant ($69,955); University of Tasmania.
  • GRANT
    Acquisition of a VS200 Research Slide Scanner for the College of Health and Medicine
    1 Jun 2022 - 31 May 2023
    People funded by this grant:
    • Sutherland B,
    • Howells D,
    • Courtney J-M,
    • King A,
    • Dickson T
    Project Total: $100,000; The Olympus VS200 Research Slide Scanner enables the imaging of entire tissue sections in an automated manner. It can acquire images from up to six fluorescent channels along with brightfield, dark field and phase contrast, and has objectives up to 100X. The robotic slide loader allows for batch scanning of up to 210 slides at a time and can accommodate multiple sizes of slides up to 4?x5? plates for large tissue sections. Our current VS120 slide scanner is already used at a maximum capacity with researchers having to book weeks in advance to scan slides. The VS200 will add further capacity and offers improved capabilities with greater optical resolution, more fluorescent channels, more batch scanning capacity and the ability to scan larger slides. Pairing this with free open source software like QuPath provides high throughput, efficient and highly accurate quantitative workflows that greatly improve productivity. Funded by: Ian Potter Foundation - Grant - Medical Research ($100,000); University of Tasmania.
  • GRANT
    Can metformin and exenatide improve brain vascular function in type 2 diabetes to reduce stroke severity?
    1 Jan 2022 - 31 Dec 2022
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Howells D,
    • Morris G
    Project Total: $68,581; People with type 2 diabetes are four times more likely to have a stroke. As well as this, data shows that diabetic individuals who have a stroke are more likely to have a more severe stroke and are far more likely to die following a stroke. The primary treatment for stroke is to remove the clot that caused the stroke in the first place so that blood flow is restored to the affected area. Commonly prescribed anti-diabetic drugs appear to reduce diabetic stroke severity and improve patient outcomes following a stroke independently of lowering blood glucose levels, but we don't know how or why this is the case. The current project will determine whether common anti-diabetic drugs, metformin and/or glucagon like peptide 1 (GLP-1) receptor agonists such as exenatide, improve the health and function of blood vessels in the diabetic brain to reduce the impact of stroke. If true, this work will demonstrate that metformin and exenatide treatment may not only be useful for lowering blood glucose levels, but also aid in reducing the burden of stroke in those with type 2 diabetes. Funded by: Diabetes Australia Research Program - Grant ($68,581); University of Tasmania.
  • GRANT
    Special delivery to the brain: Using cutting-edge ultrasound to increase drug delivery to reduce brain damage after a stroke
    1 Jan 2022 - 31 Dec 2022
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Howells D,
    • Castley H,
    • Guven N
    Project Total: $9,584; This project will investigate whether ultrasound can be used to deliver a drug, idebenone, specifically to the brain to reduce brain damage after a stroke in experimental rodents. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,584); University of Tasmania.
  • GRANT
    Do pericytes regulate skeletal muscle capillary blood flow in response to insulin?
    1 Jan 2021 - 28 Feb 2022
    People funded by this grant:
    • Premilovac D,
    • Attrill E
    Project Total: $1,500; This grant funding will enable further characterisation of pericytes in-vivo and will determine whether pericytes respond to insulin's vascular mediators in the fully intact muscle microcirculation. We anticipate this work will provide evidence for a novel biological mechanism in response to insulin that will improve our understanding of blood flow regulation at the site of nutrient exchange in muscle, the capillary. Funded by: Australian Physiological Society - Grant-PhD Student Small Grant ($1,500); University of Tasmania.
  • GRANT
    Harnessing the dual roles of pericytes to improve stroke outcomes
    1 Jan 2021 - 31 Dec 2025
    People funded by this grant:
    • Sutherland B,
    • Howells D,
    • Clarkson A,
    • Premilovac D
    Project Total: $862,943; Pericytes are cells that exclusively reside on capillaries and can actively contract or relax to modulate capillary blood flow. Pericytes also have angiogenic, stem cell and phagocytic properties that are important for brain function. In ischaemic stroke, when brain blood flow is depleted, pericytes contract and then die, leading to capillary constriction even after arterial blood flow has been restored. However, after the acute stroke period, pericytes may have an important role in brain repair. Therefore, limiting pericyte contraction acutely while promoting pericyte activity during recovery may be a novel therapeutic strategy for ischaemic stroke. Aim 1 will determine whether acute pericyte constriction of capillaries is implicated in worsening stroke outcome. We will utilise our available NG2-DsRed and PDGFR-Cre transgenic mouse lines to selectively kill (ablate) pericytes during acute period post-stroke while using our novel contrast-enhanced ultrasound paradigm to assess blood flow and stroke outcomes. In addition, we will use primary cell culture methods to analyse the secretome of neurons, astrocytes, microglia and endothelial cells following ischaemia and their effects on pericyte function. Aim 2 will investigate whether pericytes drive the recovery process of the brain following stroke. Through our aforementioned transgenic mouse lines, we will selectively ablate pericytes in the recovery phase to determine its influence on stroke outcome. We will use lineage tracing to track pericytes following stroke to determine whether pericytes migrate away from capillaries and differentiate into other cell types. Lastly, we will implant pericytes into the mouse brain post-stroke to promote recovery of the brain. This research will develop pericytes as a therapeutic target for both the acute and recovery phases of stroke, pioneering future ischaemic stroke treatment and providing novel approaches for other vascular diseases and brain injuries. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($1,725,886); University of Tasmania.
  • GRANT
    Toward targeted drug delivery to the brain using ultrasound
    1 Jan 2020 - 31 Dec 2020
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Howells D,
    • Castley H
    Project Total: $9,543; All drugs given to patients in the setting of stroke are confounded by off-target effects those drugs have on other organs in the body. This pilot project will take advantage of our newly established transcranial ultrasound methods to establish a new way to deliver drugs specifically to the brain regions affected by stroke. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,543); University of Tasmania.
  • GRANT
    The role of skeletal muscle pericytes in the development of insulin resistance: friend of foe?
    1 May 2019 - 31 Dec 2019
    People funded by this grant:
    • Premilovac D,
    • Sutherland B
    Project Total: $16,457; An important action of insulin in the body is to increase blood flow through capillaries in skeletal muscles. This vascular action of insulin occurs rapidly after insulin levels in the blood rise, for example following a meal, to ensure that both insulin and glucose are delivered to muscle cells to enable glucose removal from the blood. Importantly, the vascular action of insulin is lost early in development of insulin resistance and contributes to the progression of the disease. Where and how insulin acts in the vascular tree to increase muscle blood flow remains poorly understood, with insulin's potential direct effects on capillaries completely overlooked. The proposed NHMRC Ideas grant will seek to fill this gap in knowledge by demonstrating that insulin acts directly on pericytes, a contractile cell type that wrap around capillaries, to increase capillary blood flow and that these effects are lost during insulin resistance and type 2 diabetes. Funded by: University of Tasmania - Grant-Research Enhancement Program; University of Tasmania ($16,457).
  • GRANT
    Can idebenone be used to reduce severity of stroke?
    1 Jan 2019 - 31 Dec 2020
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Howells D,
    • Guven N,
    • Castley H
    Project Total: $9,962; There are no drugs that improve the outcomes following a stroke. We have recently identified idebenone as a neuroprotective agent during times of energy stress. This pilot project will investigate whether idebenone can be used to reduce the severity of stroke in a pre-clinical animal model. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,962); University of Tasmania.
  • GRANT
    Can anti-diabetic agents improve blood flow and outcome following stroke in type 2 diabetes?
    1 Jan 2018 - 31 Jul 2019
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Burgess J,
    • Howells D,
    • Foa L
    Project Total: $24,912; People with type 2 diabetes are four times more likely to have a stroke. Interestingly, common anti-diabetic drugs seem to improve patient outcomes following a stroke. This project will determine whether anti-diabetic drugs improve brain blood flow dynamics during and after stroke to reduce stroke severity in an animal model of type 2 diabetes. Funded by: Royal Hobart Hospital Research Foundation - Grant-Minor Project ($24,912); University of Tasmania.
  • GRANT
    Generating and characterizing a reliable rodent model type 2 diabetes
    1 Jan 2016 - 31 Dec 2016
    People funded by this grant:
    • Premilovac D,
    • Foa L,
    • Taylor B,
    • Guven N
    Project Total: $14,673; Funded by: University of Tasmania - Grant-Research Enhancement (REGS); University of Tasmania ($14,673).
  • CONSULTANCY/CONTRACT RESEARCH
    Short chain quinones against diabetic retinopathy
    1 Jan 2016 - 31 Dec 2019
    People funded by this grant:
    • Guven N,
    • Premilovac D,
    • Foa L
    Project Total: $75,174; We will test novel short chain quinones against idebenone and related compounds in a rat model of diabetic retinopathy. Funded by: Santhera Pharmaceuticals Holding AG ($75,174); University of Tasmania.
  • GRANT
    Microvascular dysfunction in adult offspring of type 2 diabetics
    1 Jul 2014 - 30 Jun 2015
    People funded by this grant:
    • Keske M,
    • Rattigan S,
    • Sharman J,
    • Russell,
    • Premilovac D
    Project Total: $20,294; Offspring from type 2 diabetics (T2D) are at much greater risk of developing diabetes than a person with no family history. The mechanism for this increase in risk is not known. This project will determine whether microvascular dysfunction in skeletal muscle and skin of first degree relatives with T2D occurs before development of insulin resistance. We will recruit people with and without family history of T2D. It will measure microvascular actions (using ultrasound) in these people before and after a mixed meal challenge. The outcomes of this study will determine whether monitoring microvasculature responses in muscle is an important 'early' strategy for assessing risk that might inform patient treatment to prevent or delay progression to insulin resistance or T2D. Funded by: Royal Hobart Hospital Research Foundation - Grant-Clinical Research ($20,294); University of Tasmania.
  • UTAS INTERNAL FUNDING
    Cardiometabolic benefits of exercise training in type 2 diabetes independent of weight loss
    30 May 2014 - 15 Jul 2016
    People funded by this grant:
    • Keske M,
    • Greenaway T,
    • Marwick T,
    • Ross R,
    • Rattigan S
    Project Total: $50,735; This project will recruit an overweight type 2 diabetes cohort, medically assessed for an exercise program. It aims to recruit some with family history of type 2 diabetes and some without. The cohort with exercise test before and after 6 weeks of the exercise program, with type 2 medications discontinued before test. The aim is to show that heart health will not be as good with family history of type 2 and that exercise will improve heart health but will be of more benefit to those with a family history than those without. Funded by: University of Tasmania; University of Tasmania.
  • GRANT
    Cardiometabolic benefits of exercise training in type 2 diabetes independent of weight loss
    University of Tasmania1 Mar 2014 - 30 Apr 2015
    People funded by this grant:
    • Keske MAV,
    • Greenaway T,
    • Marwick TH,
    • Ross RM,
    • Rattigan S
    Project Total: $50,735; This project will recruit an overweight type 2 diabetes cohort, medically assessed for an exercise program. It aims to recruit some with family history of type 2 diabetes and some without. The cohort with exercise test before and after 6 weeks of the exercise program, with type 2 medications discontinued before test. The aim is to show that heart health will not be as good with family history of type 2 and that exercise will improve heart health but will be of more benefit to those with a family history than those without. Funded by: University of Tasmania vTAHSP Demonstration Projects ($50,735)